MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]
About 150 exhibitors including corporates, Small and Medium Enterprises, vendors as well as Offices, Ministries, and Agencies are exhibiting their products and services at this year's Swakopmund International Trade Exposition (SWAiTEX).
Launched in 2...
WINDHOEK: Windhoek Mayor Queen Kamati on Tuesday acknowledged the significant economic and social contributions of the cultural and creative industries to Windhoek's economy.
Kamati, while reviewing the current affairs and developments that took plac...
